Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers

Our aim was to evaluate the immune response of healthcare workers included in the RIPOVAC study, after receiving a booster dose (third dose), in terms of intensity and persistence of induced antibodies. In the second phase of the RIPOVAC study, between December 2021 and January 2022, eight months af...

Descripción completa

Detalles Bibliográficos
Autores principales: Algarate, Sonia, Serrano, Laura, Bueno, Jessica, Herrero-Cortina, Beatriz, Alvarado, Elena, González-Barriga, María T., Ducons, María, Montero-Marco, Jesica, Arnal, Sara, Acha, Beatriz, Riesgo, María, Taboada, Ana, Sanz-Burillo, Pilar, Yuste, Cristina, Benito, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341794/
https://www.ncbi.nlm.nih.gov/pubmed/37445893
http://dx.doi.org/10.3390/ijms241310713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341794/
https://www.ncbi.nlm.nih.gov/pubmed/37445893
http://dx.doi.org/10.3390/ijms241310713

Ejemplares similares